Everolimus in the treatment of hormone receptor-positive breast cancer

M Chavez-MacGregor… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: The phosphoinositide triphosphate kinase (PI3K)/AKT/mammalian target of
rapamycin (mTOR) is a central regulatory pathway involved in cell proliferation, growth …
被引用次数：12 相关文章

Everolimus in the treatment of hormone receptor-positive breast cancer

M Chavez-MacGregor… - Expert opinion on …, 2012 - pubmed.ncbi.nlm.nih.gov
Introduction The phosphoinositide triphosphate kinase (PI3K)/AKT/mammalian target of
rapamycin (mTOR) is a central regulatory pathway involved in cell proliferation, growth …

Everolimus in the treatment of hormone receptor-positive breast cancer.

M Chavez-MacGregor… - Expert Opinion on …, 2012 - europepmc.org
The phosphoinositide triphosphate kinase (PI3K)/AKT/mammalian target of rapamycin
(mTOR) is a central regulatory pathway involved in cell proliferation, growth, differentiation …

Everolimus in the treatment of hormone receptor-positive breast cancer

M Chavez-Macgregor… - Expert Opinion on …, 2012 - mdanderson.elsevierpure.com
Introduction: The phosphoinositide triphosphate kinase (PI3K)/AKT/mammalian target of
rapamycin (mTOR) is a central regulatory pathway involved in cell proliferation, growth …

[引用][C] Everolimus in the treatment of hormone receptor-positive breast cancer

M Chavez-MacGregor… - Expert Opinion on …, 2012 - cir.nii.ac.jp
Everolimus in the treatment of hormone receptor-positive breast cancer | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学図書館の本を …